DermACELL®

Acellular dermal matrix

Dermacell is a decellularized regenerative human tissue matrix allograft processed using proprietary MATRACELL® technology from LifeNet Health.

  

LifeNet Health has over 30 years of experience in tissue processing and holds the longest-running accreditation with the American Association of Tissue Banks (AATB).1

Contact
Twitter

Related categories

DermACELL is
sterile and ≥97% donor DNA free

Sterility assurance level (SAL) 10-6 and ready to use - no rinsing required.

Dermacell is decellularized using Matracell, a proprietary and patented technology that removes at least 97% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2

After being rendered acellular, Dermacell undergoes a terminal sterilization step to ensure a Sterility Assurance Level (SAL) of 10-6.

Low-dose gamma irradiation performed at ultra-low temperatures is used to reach surgical device-grade sterility, which lowers the probability of an active organism in the graft to 1 in 1,000,000.2
DermACELL Acellular Dermal Matrix

Sterile

Sterility assurance level (SAL) 10-6.2

 

Ready to use (RTU)

No rinsing required.2

 

≥97% Donor DNA-Free

A proprietary and patented technology that removes at least 97% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2

 

Operative benefits

Dermacell provides a medical device-grade sterility assurance level of 10-6 and requires no rinsing prior to application.2 The graft features a wide suture border to further support intraoperative placement.